Related references
Note: Only part of the references are listed.Opioids in Cancer Development, Progression and Metastasis: Focus on Colorectal Cancer
Adrian Szczepaniak et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)
Postoperative administration of ketorolac averts morphine-induced angiogenesis and metastasis in triple-negative breast cancer
Zhongqi Liu et al.
LIFE SCIENCES (2020)
The μ-opioid receptor (MOR) promotes tumor initiation in hepatocellular carcinoma
Yi Li et al.
CANCER LETTERS (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
How Anesthetic, Analgesic and Other Non-Surgical Techniques During Cancer Surgery Might Affect Postoperative Oncologic Outcomes: A Summary of Current State of Evidence
Patrice Forget et al.
CANCERS (2019)
Influence or perioperative anaestnetic and analgesic interventions oncological outcomes: a narrative review
T. Wall et al.
BRITISH JOURNAL OF ANAESTHESIA (2019)
The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target
D. T. Chen et al.
BRITISH JOURNAL OF ANAESTHESIA (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Voice of cancer patients (VoCP): Analysis of experiences of cancer patients undergoing breast cancer surgery
S. Aggarwal et al.
CANCER RESEARCH (2019)
Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist
Yu-Hua Wang et al.
SCIENTIFIC REPORTS (2018)
FK866 inhibits the epithelial-mesenchymal transition of hepatocarcinoma MHCC97-H cells
Bin Zhang et al.
ONCOLOGY LETTERS (2018)
NAD Metabolism in Cancer Therapeutics
Keisuke Yaku et al.
FRONTIERS IN ONCOLOGY (2018)
Extracellular NAMPT/Visfatin induces proliferation through ERK1/2 and AKT and inhibits apoptosis in breast cancer cells
Zafar Gholinejad et al.
PEPTIDES (2017)
Targeting metabolic pathways for head and neck cancers therapeutics
Masashi Yamamoto et al.
CANCER AND METASTASIS REVIEWS (2017)
The NAD+ salvage pathway modulates cancer cell viability via p73
T. Sharif et al.
CELL DEATH AND DIFFERENTIATION (2016)
Regional anaesthesia and analgesia: relationship to cancer recurrence and survival
T. Tedore
BRITISH JOURNAL OF ANAESTHESIA (2015)
The Mu Opioid Receptor: A New Target for Cancer Therapy?
Patrick A. Singleton et al.
CANCER (2015)
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
James A. Maier et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2015)
Physiological and pathophysiological roles of NAMPT and NAD metabolism
Antje Garten et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression
Sabrina Bimonte et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review
J. W. Boland et al.
BRITISH JOURNAL OF CANCER (2014)
Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer
Antonio F. Santidrian et al.
DNA REPAIR (2014)
Opioid Requirement, Opioid Receptor Expression, and Clinical Outcomes in Patients With Advanced Prostate Cancer
Dylan Zylla et al.
CANCER (2013)
The Role of Morphine in Animal Models of Human Cancer: Does Morphine Promote or Inhibit the Tumor Growth?
Sabrina Bimonte et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
Ilirjana Bajrami et al.
EMBO MOLECULAR MEDICINE (2012)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents
Javed A. Khan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)